Voyager Biomedical, Inc.

HOUSTON, TX · Founded 2016 · Medtech · Private

A porous titanium vascular access device that integrates with tissue to create a palpable target for reliable arteriovenous fistula cannulation in dialysis patients

Claim this profile

Follows are private to you and power your alerts

Updated · voyagerbiomedical.com

Sector
Medtech
Headquarters
HOUSTON, TX
Founded
2016
Latest Form D
$5.8M, Apr 2025
Total capital
$6.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$6.8M
2 Form D · last Apr 2025
19 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
9 pending · first 2021
Rank in peer group#370 of 1112

Capital timeline

202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $6.8M1st Form D$995K2nd Form D$5.8M
202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $6.8M1st Form D$995K2nd Form D$5.8M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$5.8M
  • Private capital raisedForm D · SEC · 1st filing$995K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Alan GlowczwskiResearcherExecutive Officer, DirectorLinked by 2 patents
  • Ashok GowdaResearcherDirectorLinked by 1 patent
  • April LoveladyPromoterNamed in SEC Form D filings
  • Bruce ShookDirectorNamed in SEC Form D filings
  • Linda SpainExecutive Officer, DirectorNamed in SEC Form D filings
  • Marcus PennaExecutive Officer, DirectorNamed in SEC Form D filings
Show all 11 people
  • Monica KlosExecutive OfficerNamed in SEC Form D filings
  • Nathan BorgfeldPromoterNamed in SEC Form D filings
  • Peter SmithPromoterNamed in SEC Form D filings
  • Robert SmithPromoterNamed in SEC Form D filings
  • Trevor UhlDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 12
Show all 12 patent records
  • External Needle Guide And AnchorMar 24, 2026 · US 12,582,436Granted
  • Vascular Access Channel And MethodsJul 4, 2024 · Application 18609811Pending
  • Vascular Access Channel And MethodsApr 2, 2024 · US 11,944,774Granted
  • Vascular Access Device With Vessel AccomodationJan 4, 2024 · Application 18037703Pending
  • Vascular Access Device With Arteriovenous Fistula SupportOct 13, 2022 · Application 17766054Pending
  • Vascular Access Channel And MethodsFeb 2, 2021 · US 10,905,867Granted
  • Vascular Access Device With Arteriovenous Fistula SupportApplication PCTUS2020054169Pending
  • External Needle GuideApplication 62980036Pending
  • Vascular Port With Arteriovenous Fistula SupportApplication 62910984Pending
  • Vascular Access Device With Vessel AccomodationApplication 63115981Pending
  • External Needle Guide And AnchorApplication PCTUS2021019076Pending
  • Vascular Access Device With Vessel AccomodationApplication PCTUS2021060069Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .